Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian

Breadcrumb

  1. Home
  2. Microbiota 18 - May 2023
  3. Artificial sweeteners, gut microbiota and metabolic health: an interaction requiring close examination
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
    • International Microbiota Observatory
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Microbiota 18 - May 2023
  3. Artificial sweeteners, gut microbiota and metabolic health: an interaction requiring close examination
Gastroenterology

Artificial sweeteners, gut microbiota and metabolic health: an interaction requiring close examination

Diet
Gastroenterology

By Pr. Karine Clément
Sorbonne University, Inserm, Unité de recherche nutrition et obésités ; approches systémiques [Nutrition and Obesity Research Unit (systemic approaches)], Paris, France; Nutrition Department, Assistance-Publique - Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
    • International Microbiota Observatory
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Sections

About this article

Created 07 June 2023
Updated 08 June 2023

Sweeteners are considered as a worthy alternative to the excessive use of simple sugars, which are considered to be harmful to cardiometabolic health [1]. Sweeteners can be consumed directly or in processed products [2] In Cell, Suez et al. reported the results of a randomised controlled trial which showed that, paradoxically, some sweeteners may disturb glucose tolerance and that some effects are mediated by changes in the gut microbiota [3].

How do you explain that only two sweeteners have an effect on blood sugar levels (saccharin and sucralose) while the four sweeteners tested had an impact on the composition and functions of the gut microbiota?

The use of sweeteners can be suggested in people with metabolic diseases to help them reduce their calorie intake, lose weight and improve their metabolic risk [4]. However, over time, concerns have emerged due to the fact that sweeteners do not have a neutral effect [5, 6]. In 2014, the authors of this publication had already shown that mice consuming high doses of aspartame, saccharin and sucralose developed glucose intolerance due to disturbances in the gut microbiota [7]. In this new research, they have gone one step further by carrying out a well-conducted clinical study in humans. In 120 healthy participants, the researchers assessed the effects on glucose tolerance of sucralose, saccharin, stevia and aspartame administered for 14 days (5 study arms, 20 participants per group and one control group). Sweeteners were used at levels lower than the recommended daily intake. The ingestion of sucrose and sucralose aggravated glucose tolerance, while aspartame and stevia had a neutral effect. These sweeteners had distinct effects on the composition of the oral and faecal microbiota and on key functions (such as purine and pyrimidine metabolism, glycolysis, and amino-acid metabolism). The most significant effect was observed with sucralose. Microbiota transfer studies (human to mouse) have established the causality of effects. Animals colonised with samples from sweetener-supplemented subjects showed varying degrees of altered glucose tolerance. The chemical composition of sweeteners appears to influence the microbiota; however, the precise mechanism by which they exert these variable effects on the host through changes in the faecal microbiota requires further detailed study. More specifically, sucralose, saccharin and stevia are partially metabolised in the upper digestive tract and only a tiny proportion reaches the colon.

Does this mean you recommend that your patients should not use non-nutritive sweeteners, since they may not be physiologically inert?

In my clinical practice, we do not systematically suggest patients use sweeteners, as there is no evidence that they are an effective weight-loss tool. Although, in patients who are unable to lose their sweet tooth, we prefer suggesting the use of natural sweeteners such as steviol glucoside, which can be used on a short-term and reasonable basis. However, the above discussed results highlight the need for a rigorous assessment of the short- and longterm impact of the available sweeteners on human health before deciding whether or not to recommend their continued use as an aid to reducing metabolic risks.

Sources

1. Andrade L, Lee KM, Sylvetsky AC, Kirkpatrick SI. Low-calorie sweeteners and human health: a rapid review of systematic reviews. Nutr Rev 2021 ; 79 : 1145-64.
2. Carocho M, Morales P, Ferreira ICFR. Sweeteners as food additives in the XXI century: A review of what is known, and what is to come. Food Chem Toxicol 2017 : 107 : 302-17.
3. Suez J, Cohen Y, Valdés-Mas R, et al. Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell 2022 ; 185 : 3307-28.e19.
4. McGlynn ND, Khan TA, Wang L, et al. Association of low- and no-calorie sweetened beverages as a replacement for sugar-sweetened beverages with body weight and cardiometabolic risk: a systematic review and meta-analysis. JAMA Netw Open 2022 ; 5 : e222092.
5. Humphries P, Pretorius E, Naudé H. Direct and indirect cellular effects of aspartame on the brain. Eur J Clin Nutr 2008 ; 62 : 451-62.
6. Wu GD, Chen J, Hoffman C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011 ; 334 : 105-8.
7. Suez J, Korem T, Zeevi D, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014 ; 514 : 181-6.

Tags
Food Sugar Diabetes Obesity Diet Gut microbiota Metabolic

en_view en_sources

    Focus
    Microbiota 18 - May 2023
    • Overview
      • Oral microbiota and chronic conditions
    • Commented article
      • A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumours
      • Rural environment reduces allergic inflammation by modulating the gut microbiota
    • Congress review
      • Highlights of Gut Microbiota for Health - World Summit 2023
    • Press review
      • Gut Microbiota #18
      • Vaginal Microbiota #18
      • Urinary and Urethral Microbiota #18
    • Expert opinion
      • Artificial sweeteners, gut microbiota and metabolic health: an interaction requiring close examination
    Created 07 June 2023
    Updated 08 June 2023

    About this article

    To know more about this topic.

    Main topic

    Diet

    Medical practice

    Gastroenterology

    Content type

    Expert opinion
    Urinary and Urethral Microbiota #18
    Focus

    Microbiota 18 - May 2023

    Overview

    Oral microbiota and chronic conditions

    Commented article

    A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumours Rural environment reduces allergic inflammation by modulating the gut microbiota

    Congress review

    Highlights of Gut Microbiota for Health - World Summit 2023

    Press review

    Gut Microbiota #18 Vaginal Microbiota #18 Urinary and Urethral Microbiota #18

    Expert opinion

    Artificial sweeteners, gut microbiota and metabolic health: an interaction requiring close examination
    Gastroenterology

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irritable Bo...

    Find out more
    26.07.2023

    Unexpected effect of famous antibiotic on fungal microbiota

    Read the article

    A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumours

    COMMENTED ARTICLE - ADULTS’ SECTION By Pr. Harry SokolGa...

    Find out more
    L’axe intestin-cerveau dans le stress lié à la discrimination
    20.03.2023

    The gut-brain axis and discrimination-related stress

    Read the article
    21.09.2023

    The mucin-microbiota pair - central to the development of gastric cancer?

    Read the article
    25.10.2022

    Antibiotics: Dr Jekyll and Mr Hyde

    Read the article
    13.09.2023

    Parkinson’s disease: Desulfovibrio bacteria have been found guilty

    Read the article
    18.11.2020

    Gut microbiota signature for cirrhosis

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    Microbiota 17 EN
    Check out our latest magazine
    The first 1000 days of life
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
      • International Microbiota Observatory
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
      • International Microbiota Observatory
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    21.09.2023

    The mucin-microbiota pair - central to the development of gastric cancer?

    Read the article
    13.09.2023

    Parkinson’s disease: Desulfovibrio bacteria have been found guilty

    Read the article
    29.08.2023

    Massive amounts of antibiotic resistance genes found in clouds

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
      • International Microbiota Observatory
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo